Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Chronic Recurrent Multifocal Osteomyelitis (CRMO): Diagnosis and Treatment Pathways

Plays: 862

Video Description

CRMO is an autoinflammatory bone disorder that almost exclusively affects the skeletally immature –– children and adolescents. CRMO often resolves once they reach skeletal maturity. Since CRMO is a diagnosis of exclusion, biopsies, MRIs and genetic testing are often needed to rule out more serious causes of symptoms (e.g., bone pain, weakness, weight loss), such as leukemia, lymphoma, bacterial osteomyelitis, Ewing sarcoma and Langerhan’s cell histiocytosis.

In this video, Associate Professor of Orthopedic Surgery Nathan Donaldson, DO, discusses the use of radiographs and MRIs for imaging and the importance of biopsies to confirm CRMO diagnosis. CRMO treatment options include NSAIDs, methotrexate, TNF inhibitors or biphosphanates with a goal of being pain-free for 6 months prior to stopping treatment.

For more information, visit https://www.childrenscolorado.org/doctors-and-departments/departments/rheumatology/.

Connect with Children’s Colorado:

Instagram: https://www.instagram.com/childrenscolo
Facebook: https://www.facebook.com/childrenshospitalcolorado
Twitter: https://twitter.com/ChildrensCO_Pro

LinkedIn: https://www.linkedin.com/company/children's-hospital-colorado

Website: http://www.childrenscolorado.org



Please rate video.

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

Average 4.5 of 2 Ratings

Related Videos
Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options